Case number 1:17-cv-00852
Biogen International GmbH et al v. Glenmark Pharmaceuticals Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 11 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jul 8, 2020 | 1 | Complaint (16) |
| Nov 22, 2019 | 22 | Patent/Trademark Report to Commissioner (1) |
| Nov 22, 2019 | 22 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # (1) Stipulation of Dismissal)(mdb) |
| Nov 22, 2019 | 22 | Stipulation of Dismissal (4) |
| Nov 22, 2019 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. 338 in Lead Case 17-823. (dlw) |
| Nov 13, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:17-cv-00823-MN through 1:17-cv-00825-MN, 1:17-cv-00828-MN, 1:17-cv-00845-MN through 1:17-cv-00847-MN, 1:17-cv-00849-MN through 1:17-cv-00857-MN, 1:17-cv-00872-MN, 1:17-cv-00874-MN, 1:17-cv-00875-MN, 1:17-cv-00954-MN, 1:18-cv-00337-MN, 1:18-cv-00623-MN, 1:18-cv-01361-MN, 1:19-cv-00303-MN, and 1:19-cv-00333-MN (rjb) |
| Sep 7, 2018 | N/A | Case Stayed (0) Docket Text: Case Stayed (See D.I. 160 in lead case no. 17-823-LPS) (ntl) |
| Mar 19, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 22 was removed from the docket per request of counsel (to be re-filed in the lead case). (ntl) |
| Feb 2, 2018 | N/A | Create Case Association (0) |
| Feb 2, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00824-LPS et al.(dlb) |
| Feb 2, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-00823-LPS. (ntl) |
| Jan 31, 2018 | 21 | Proposed Order (22) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Jan 31, 2018 | 20 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Proposed Scheduling Order. (Balick, Steven) |
| Jan 23, 2018 | 19 | Transcript (35) Docket Text: Official Transcript of Scheduling Telephone Conference held on January 17, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/13/2018. Redacted Transcript Deadline set for 2/23/2018. Release of Transcript Restriction set for 4/23/2018.(bpg) |
| Jan 17, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 1/17/2018. (Court Reporter B. Gaffigan.) Associated Cases: 1:17-cv-00823-LPS et al. (ntl) |
| Dec 28, 2017 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that a Rule 16 scheduling teleconference has been scheduled for January 17, 2018 at 9:30 AM. Plaintiffs counsel shall initiate the teleconference call to 302-573-4571. No further submissions are necessary. ORDERED by Judge Leonard P. Stark on 12/28/2017. Associated Cases: 1:17-cv-00823-LPS et al.(etg) |
| Dec 20, 2017 | 17 | Proposed Order (25) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Dec 20, 2017 | 16 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Proposed Scheduling Order. (Balick, Steven) |
| Dec 20, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:17-cv-00824-LPS, 14 in 1:17-cv-00856-LPS, 14 in 1:17-cv-00872-LPS, 14 in 1:17-cv-00848-LPS, 14 in 1:17-cv-00849-LPS, 17 in 1:17-cv-00845-LPS, 16 in 1:17-cv-00846-LPS, 12 in 1:17-cv-00847-LPS, 15 in 1:17-cv-00851-LPS, 15 in 1:17-cv-00823-LPS, 15 in 1:17-cv-00852-LPS, 16 in 1:17-cv-00857-LPS, 16 in 1:17-cv-00828-LPS, 17 in 1:17-cv-00875-LPS, 13 in 1:17-cv-01361-LPS, 19 in 1:17-cv-00825-LPS, 15 in 1:17-cv-00829-LPS, 15 in 1:17-cv-00855-LPS, 17 in 1:17-cv-00827-LPS, 17 in 1:17-cv-00853-LPS, 16 in 1:17-cv-00826-LPS, 15 in 1:17-cv-00874-LPS, 12 in 1:17-cv-00954-LPS, 14 in 1:17-cv-00854-LPS, 17 in 1:17-cv-00850-LPS) STIPULATION Seeking to Extend the Deadline by Which the Parties Must Submit a Proposed Scheduling Order, by Biogen International GmbH, Biogen MA Inc. Signed by Judge Leonard P. Stark on 12/20/2017. Associated Cases: 1:17-cv-00823-LPS et al.(etg) |
| Dec 15, 2017 | 15 | Stipulation (12) Docket Text: STIPULATION Seeking to Extend the Deadline by Which the Parties Must Submit a Proposed Scheduling Order, by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Nov 29, 2017 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than December 15, 2017. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 11/29/17. Associated Cases: 1:17-cv-00823-LPS et al. (ntl) |
| Nov 13, 2017 | 13 | Answer to Counterclaim (9) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Biogen International GmbH, Biogen MA Inc..(Mayo, Andrew) |
| Nov 7, 2017 | N/A | SO ORDERED (0) |
| Nov 6, 2017 | 12 | Stipulation to EXTEND Time (9) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to Respond to Defendants' Counterclaims to November 13, 2017 - filed by Biogen International GmbH, Biogen MA Inc.. (Mayo, Andrew) |
| Oct 19, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin E. Warner for Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Oct 19, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Oct 17, 2017 | N/A | SO ORDERED (0) |
| Oct 16, 2017 | 11 | Certification of Dan H. Hoang (1) |
| Oct 16, 2017 | 11 | Certification of Katherine D. Hundt (1) |
| Oct 16, 2017 | 11 | Certification of John R. McNair (1) |
| Oct 16, 2017 | 11 | Certification of Kevin E. Warner (1) |
| Oct 16, 2017 | 11 | Certification of Maureen L. Rurka (1) |
| Oct 16, 2017 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Glenmark Pharmaceuticals Limited for Glenmark Pharmaceuticals Inc., USA filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Phillips, John) |
| Oct 16, 2017 | 9 | Answer to Complaint (25) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Phillips, John) |
| Oct 16, 2017 | 11 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Maureen L. Rurka, Kevin E. Warner, John R. McNair, Dan H. Hoang and Katherine D. Hundt - filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Attachments: # (1) Certification of Maureen L. Rurka, # (2) Certification of Kevin E. Warner, # (3) Certification of John R. McNair, # (4) Certification of Dan H. Hoang, # (5) Certification of Katherine D. Hundt)(Bilson, David) |
| Aug 29, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 4, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 3, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 3, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 3, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jul 26, 2017 | N/A | SO ORDERED (0) |
| Jul 24, 2017 | 8 | Motion for Leave to Appear Pro Hac Vice (14) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Sanya Sukduang, Li Feng, and Andrew E. Renison - filed by Biogen International GmbH, Biogen MA Inc.. (Mayo, Andrew) |
| Jul 21, 2017 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biogen Inc. for Biogen International GmbH, Biogen MA Inc. filed by Biogen International GmbH, Biogen MA Inc.. (Mayo, Andrew) |
| Jul 13, 2017 | N/A | SO ORDERED (0) |
| Jul 12, 2017 | 6 | Stipulation (2) Docket Text: STIPULATION regarding Waiver of Service and Extension of Deadlines, by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) |
| Jul 5, 2017 | N/A | Case Assigned/Reassigned (0) |
| Jun 30, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Glenmark Pharmaceuticals Inc., USA on 6/30/2017. (jcs) |
| Jun 30, 2017 | 5 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Biogen MA Inc., Biogen International GmbH. Glenmark Pharmaceuticals Inc., USA served on 6/30/2017, answer due 7/21/2017. (Mayo, Andrew) |
| Jun 28, 2017 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmg) |
| Jun 28, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,320,999; 6,509,376; 8,399,514. (nmg) |
| Jun 28, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/2/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/27/2020. (nmg) |
| Jun 28, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jun 28, 2017 | 1 | Civil Cover Sheet (3) |
| Jun 28, 2017 | 1 | Exhibit C (30) |
| Jun 28, 2017 | 1 | Main Document (16) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2173561.) - filed by Biogen MA Inc., Biogen International GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Civil Cover Sheet)(nmg) |
| Jun 28, 2017 | 1 | Exhibit B (8) |
| Jun 28, 2017 | 1 | Exhibit A (7) |
| Jun 28, 2017 | 1 | Complaint* (1) |
